Home
AGEN
AGEN News

Latest Agenus Inc. (AGEN) News on December 23, 2024

Business Wire

5 days ago

Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

BioPharma Dive

17 days ago

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

Business Wire

18 days ago

Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs

Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

Benzinga

25 days ago

Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

MT Newswires

25 days ago

Agenus Secures $22 Million Mortgage, Plans Operational Realignment; Shares Jump

Business Wire

a month ago

Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment

Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a month ago

Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a month ago

Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround

Zacks

a month ago

Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround

Thomson Reuters StreetEvents

a month ago

Q3 2024 Agenus Inc Earnings Call

Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ...

GuruFocus.com

a month ago

Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ...

Agenus (AGEN) Q3 2024 Earnings Call Transcript

Motley Fool

a month ago

Agenus (AGEN) Q3 2024 Earnings Call Transcript

Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates

Zacks

a month ago

Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates

Associated Press Finance

a month ago

Agenus: Q3 Earnings Snapshot

Business Wire

a month ago

Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development

Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result

GuruFocus.com

a month ago

Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result

Business Wire

a month ago

Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024

Business Wire

2 months ago

Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update

Business Wire

3 months ago

Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024

MT Newswires

3 months ago

Agenus Sued by Shareholder for Misleading Investors Over Colorectal Cancer Immuno-Therapy Trial Results

Business Wire

3 months ago

Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024

Business Wire

4 months ago

Agenus to Participate in September Investor Conferences

Agenus (AGEN) Q2 2024 Earnings Call Transcript

Motley Fool

4 months ago

Agenus (AGEN) Q2 2024 Earnings Call Transcript

Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates

Zacks

4 months ago

Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates

Associated Press Finance

4 months ago

Agenus: Q2 Earnings Snapshot

Business Wire

4 months ago

Agenus Reports Second Quarter 2024 Operational and Financial Results

Business Wire

4 months ago

Agenus Announces Appointment of Tom Harrison to Board of Directors

Business Wire

4 months ago

Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus

Benzinga

5 months ago

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus

Bristol Myers sends TIGIT drug back to Agenus

BioPharma Dive

5 months ago

Bristol Myers sends TIGIT drug back to Agenus

Agenus (AGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Zacks

5 months ago

Agenus (AGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

Zacks

5 months ago

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

Business Wire

5 months ago

Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update

Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data

Zacks

5 months ago

Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

BioPharma Dive

5 months ago

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

MT Newswires

5 months ago

Agenus Says FDA Advised Against Accelerated Approval for Potential Colorectal Cancer Treatment; Shares Tumble

Business Wire

5 months ago

Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer

IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?

Zacks

5 months ago

IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?

MT Newswires

6 months ago

Sector Update: Health Care Stocks Edge Higher in Afternoon Trading

MT Newswires

6 months ago

Agenus Shares Rise After Trial Shows Tumor Reductions in Colon Cancer Patients

Business Wire

6 months ago

Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference

Business Wire

6 months ago

Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies

Business Wire

6 months ago

Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors

Business Wire

6 months ago

Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

6 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

6 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

6 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

6 months ago

New Zealand scraps plan to tax livestock burps, farts

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

6 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

Business Wire

6 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

6 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

6 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Business Wire

7 months ago

Agenus Announces Virtual Annual Shareholders Meeting

Business Wire

7 months ago

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

7 months ago

Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting

Business Wire

7 months ago

Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

3 Magnificent Growth Stocks to Buy Hand Over Fist

Motley Fool

7 months ago

3 Magnificent Growth Stocks to Buy Hand Over Fist

Business Wire

7 months ago

FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer

Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript

Agenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

7 months ago

Agenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

GuruFocus.com

7 months ago

Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...

Agenus (AGEN) Q1 2024 Earnings Call Transcript

Motley Fool

8 months ago

Agenus (AGEN) Q1 2024 Earnings Call Transcript

MT Newswires

8 months ago

Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading

MT Newswires

8 months ago

Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates

Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates

Zacks

8 months ago

Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates

Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments

GuruFocus.com

8 months ago

Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments

Associated Press Finance

8 months ago

Agenus: Q1 Earnings Snapshot

Business Wire

8 months ago

Agenus Reports First Quarter 2024 Results

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

Business Wire

8 months ago

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

Business Wire

8 months ago

Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement

Up 40%: Is This Red-Hot Growth Stock Still a Buy?

Motley Fool

8 months ago

Up 40%: Is This Red-Hot Growth Stock Still a Buy?

Business Wire

8 months ago

Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting

Business Wire

8 months ago

Agenus to Provide First Quarter 2024 Financial Report and Corporate Update

Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?

Zacks

8 months ago

Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?

Business Wire

8 months ago

Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer

Down 75%. Is Agenus Stock a Buy on the Dip?

Motley Fool

8 months ago

Down 75%. Is Agenus Stock a Buy on the Dip?

Business Wire

9 months ago

Agenus Announces Reverse Stock Split of Common Stock

2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?

Motley Fool

9 months ago

2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?

US$5.50: That's What Analysts Think Agenus Inc. (NASDAQ:AGEN) Is Worth After Its Latest Results

Simply Wall St.

9 months ago

US$5.50: That's What Analysts Think Agenus Inc. (NASDAQ:AGEN) Is Worth After Its Latest Results

Agenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Agenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript

Analysts Just Shaved Their Agenus Inc. (NASDAQ:AGEN) Forecasts Dramatically

Simply Wall St.

9 months ago

Analysts Just Shaved Their Agenus Inc. (NASDAQ:AGEN) Forecasts Dramatically

Agenus (AGEN) Q4 2023 Earnings Call Transcript

Motley Fool

9 months ago

Agenus (AGEN) Q4 2023 Earnings Call Transcript

Agenus Inc (AGEN) Reports Full Year and Q4 2023 Financial Results, Advances in Oncology Pipeline

GuruFocus.com

9 months ago

Agenus Inc (AGEN) Reports Full Year and Q4 2023 Financial Results, Advances in Oncology Pipeline

Associated Press Finance

9 months ago

Agenus: Q4 Earnings Snapshot

Business Wire

9 months ago

Agenus Reports Fourth Quarter and Full Year 2023 Results

Business Wire

10 months ago

Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024

Business Wire

10 months ago

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

10 months ago

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

Business Wire

10 months ago

Agenus to Participate in Leerink Partners Global Biopharma Conference

Favourable Signals For Agenus: Numerous Insiders Acquired Stock

Simply Wall St.

10 months ago

Favourable Signals For Agenus: Numerous Insiders Acquired Stock

Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today

Motley Fool

10 months ago

Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today

Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design

PR Newswire

10 months ago

Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design

7 Analyst-Backed Stocks With Promising 10-Bagger Potential

InvestorPlace

a year ago

7 Analyst-Backed Stocks With Promising 10-Bagger Potential

Business Wire

a year ago

Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024

InvestorPlace

a year ago

3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024

While institutions own 25% of Aris Mining Corporation (TSE:ARIS), retail investors are its largest shareholders with 59% ownership

Simply Wall St.

a year ago

While institutions own 25% of Aris Mining Corporation (TSE:ARIS), retail investors are its largest shareholders with 59% ownership

Summit Financial Group Reports Earnings of $1.11 Per Share for Fourth Quarter 2023

GlobeNewswire

a year ago

Summit Financial Group Reports Earnings of $1.11 Per Share for Fourth Quarter 2023

Resources Connection (NASDAQ:RGP) Will Pay A Dividend Of $0.14

Simply Wall St.

a year ago

Resources Connection (NASDAQ:RGP) Will Pay A Dividend Of $0.14

Green Brick Partners (GRBK) Posted a 114% Gain in 2023

Insider Monkey

a year ago

Green Brick Partners (GRBK) Posted a 114% Gain in 2023

Business Wire

a year ago

Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population

Share on Social Networks: